dc.contributor.author |
Rakhimova M., Akhmedov Kh., Rakhimova O. |
|
dc.date.accessioned |
2024-12-17T01:10:30Z |
|
dc.date.available |
2024-12-17T01:10:30Z |
|
dc.date.issued |
2024 |
|
dc.identifier.citation |
Toshkent |
en_US |
dc.identifier.issn |
2181-7812 |
|
dc.identifier.uri |
http://repo.tma.uz/xmlui/handle/1/371 |
|
dc.description.abstract |
Study of endothelial dysfunction against the background of systemic inflammation in patients with an- kylosing spondylitis who have had COVID-19. Material and methods: The study included 80 patients diagnosed with ankylosing spondylitis according to the modified New York criteria and EULAR. All patients were divided into 2 groups: 1st group - 40 patients with ankylosing spondylitis without a post-Covid period, 2nd - 40 patients with ankylosing spon- dylitis and a post-COVID period. The control group consist- ed of 40 healthy people with no history of acute or chronic diseases. Results: In patients with ankylosing spondylitis, survivors of COVID-19 and healthy people, there was no significant correlation between gender, age, serum lipids, smoking habit, C-reactive protein level and disease activity, although for some of of these variables, this may have oc- curred due to the small number of subjects included in the study. Conclusions: The lack of correlation between FMD indicators and disease activity should be confirmed by fur- ther studies with a larger number of subjects. |
en_US |
dc.language.iso |
en |
en_US |
dc.relation.ispartofseries |
UDK;616-008:616.13-02:612.017.1-616-074-08 |
|
dc.subject |
ankylosing spondylitis, COVID-19, endo- thelial dysfunction. |
en_US |
dc.title |
Endothelial dysfunction in patients with ankylosing spondylitis after covid-19 |
en_US |
dc.type |
Article |
en_US |